News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Valeant Pharmaceuticals International
NEWS
IN THE PRESS
NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Biotech Bay
Why Eli Lilly and Company May Never Get Bought By Valeant Pharmaceuticals International -- Or Anyone Else
June 25, 2014
·
1 min read
Biotech Beach
The Flip Side: What Valeant Pharmaceuticals International Gets Right About R&D
June 17, 2014
·
1 min read
Biotech Bay
Valeant Pharmaceuticals International’s Debate About Research Are Misleading, Wrong
June 13, 2014
·
1 min read
Biotech Bay
Why Valeant Pharmaceuticals International’s Allergan Inc. R&D Bid Does Not Make Sense
May 28, 2014
·
1 min read
Biotech Bay
Billionaire Outs Valeant Pharmaceuticals International CEO As A Billionaire
April 23, 2014
·
1 min read
Business
Valeant Pharmaceuticals International CEO’s Pay Package Draws Praise as a Model
August 24, 2009
·
1 min read
Drug Development
Valeant Pharmaceuticals International Chemo Drug Cream May Fade Wrinkles, University of Michigan Study
June 16, 2009
·
1 min read
Deals
Valeant Pharmaceuticals International Sells Pan-Asia Marketing Rights to Invida
March 3, 2008
·
1 min read
Biotech Beach
The Day In Review: SciClone Pharmaceuticals, Inc. Soars On Positive Melanoma Results
December 22, 2006
·
1 min read
IN THE PRESS
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021
November 27, 2018
·
3 min read
Policy
Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10%
October 1, 2018
·
5 min read
Business
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
August 13, 2018
·
4 min read
Drug Development
Strategic appointment expands Atlantic Healthcare executive team
August 8, 2018
·
7 min read
Policy
Virtus Thwarts Efforts of Bausch Health (formerly known as Valeant) to Push Lower Priced Competing Drugs off the Market
August 1, 2018
·
1 min read
Business
Bausch Health Companies Inc. Completes Name Change
July 13, 2018
·
3 min read
FDA
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 9, 2018
·
3 min read
FDA
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion
June 18, 2018
·
3 min read
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops
June 14, 2018
·
4 min read
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins
June 12, 2018
·
4 min read